TikaMobile, Inc. a cloud-based analytics and CRM technology company for the life sciences industry, today announced that it was selected to be the business intelligence reporting platform for the TherapeuticsMD sales force in preparation for the potential launch of TherapeuticsMD’s TX-004HR drug candidate, if approved. TherapeuticsMD intends to leverage TikaMobile’s powerful and user-friendly proprietary analytics platform to empower its sales force with data and provide leadership with up-to-date information to assess sales performance and make strategic decisions with speed and accuracy.
Mitchell Krassan, Chief Performance Officer at TherapeuticsMD, said, “We needed a scalable and easy-to-use sales solution that provides our sales force with data driven, actionable insights necessary for the successful launch of our first drug candidate, if approved. A successful drug launch requires real-time insights that help to quickly identify opportunities and focus information on the critical steps to drive our business initiatives. We feel that the TikaPharma platform is the perfect solution to deliver this intelligence in a user-friendly experience.”
“We are excited to work and collaborate with the TherapeuticsMD team to drive best practices through their sales team using our powerful, user-friendly technology and analytics platform,” said Manish Sharma, CEO of TikaMobile. “Pharmaceutical and biotech companies recognize the urgency to attain a competitive level of analytical sophistication and are turning to Tika as a proven cloud technology provider to gain that edge. Our vision is to work with life sciences companies to optimize their sales productivity and drive revenue by providing real time, on-demand access to business intelligence as well as interactive, actionable analytics through our powerful and easy-to-use platform.”
“We understand the day-in-the-life of the sales rep and we designed TikaMobile to be the one cohesive best-in-class business intelligence tool that brings together everything the sales rep needs to be more productive and successful in the field,” said Rob Thomas, VP of Sales & Marketing at TikaMobile.
About TikaMobile, Inc.
TikaMobile, Inc. is the premier leader in cloud-based business intelligence and CRM sales enablement software for the global life sciences industry. By combining many disparate sales and marketing tools into a single easy-to-use application, while applying prescriptive, actionable analytics across the commercial organization, Tika is transforming and optimizing sales organizations for pharmaceutical and medical device companies. Tika is committed to innovation, product excellence, and customer success and works with organizations of all sizes. Headquartered in New York City, Tika has offices in the United States, Europe and India. For more information, visit www.TikaMobile.com.
TherapeuticsMD, Inc. is an innovative healthcare company focused on developing and commercializing products exclusively for women. With its SYMBODA™ technology, TherapeuticsMD is developing advanced hormone therapy pharmaceutical products to enable delivery of bio-identical hormones through a variety of dosage forms and administration routes. The Company’s late stage clinical pipeline includes two product candidates that have completed phase 3 trials and are awaiting approval by the FDA: TX-001HR for treatment of moderate-to-severe vasomotor symptoms (VMS) due to menopause and TX-004HR for treatment of moderate-to-severe vaginal pain during sexual intercourse (dyspareunia), a symptom of vulvar and vaginal atrophy (VVA) due to menopause. The Company also manufactures and distributes branded and generic prescription prenatal vitamins under the vitaMedMD® and BocaGreenMD® brands.
Director, Investor Relations